governance factors – have doubled to approximately $9.5 billion from $4 billion in 2012. “ESG and impact investing are key components of many of our clients’ investment programs today, and the number of ESG investing opportunities has increased dramatically,” said O’Neill. “We are delighted that Christie is leading the next generation of our MRI research as the opportunity landscape continues to expand. Appointing someone as experienced in the field as Christie to lead ESG and impact research is a natural step for Cambridge Associates as the robustness of our MRI efforts and their importance to our clients continues to increase and expand.” “It’s an extraordinary time in ESG and impact investing,” said Zarkovich. “Institutional investors are becoming increasingly interested and proactive in aligning their investment portfolios with the institution’s long-term goals and mission. As with any other asset class, extensive manager due diligence and access to talent and resources to uncover the best investment ideas is critical to delivering performance, but the range of opportunities where strong performance and impact are inextricably linked continues to grow.” Cambridge Associates formally established its MRI practice in 2008 to stay ahead of the increasing demand from clients to invest in strategies that align with their overall missions and ESG priorities. The firm has 35 ESG- and MRI-focused investment professionals around the world serving firm’s core client segments, which include endowments, foundations, private clients and pensions. On average, Cambridge Associates conducts approximately 300 due diligence meetings a year with ESG- and MRI-related investment managers, with a proprietary database that includes over 1,000 MRI strategies that have been vetted for client portfolios over the last decade. Areas within MRI research include climate change and impact themes such as education, community development, health and wellness, social justice, and more. Before joining Cambridge Associates, Zarkovich served as a Managing Director at Perella Weinberg Partners in Denver, where she was a member of the Investment Committee and helped manage $6 billion in foundation and endowment assets on a discretionary basis. She had previously been a senior member of the investment team at The William and Flora Hewlett Foundation and started her career at the New York Mercantile Exchange. She holds a Bachelor’s in Economics from The Colorado School of Mines and an MBA and MS Finance from the University of Denver. She is a CFA charterholder. To learn more about Cambridge Associates’ MRI expertise or speak with Christie Zarkovich, please contact Katarina Wenk-Bodenmiller: email@example.com or 212-255-8386. About Cambridge Associates
Cambridge Associates is a leading global investment firm. We aim to help endowments & foundations, pension plans, and private clients implement and manage custom investment portfolios that generate outperformance so they can maximize their impact on the world. Working alongside its early clients, among them leading university endowments, the firm pioneered the strategy of high-equity orientation and broad diversification, which since the 1980s has been a primary driver of performance for institutional investors. Cambridge Associates delivers a range of services, including outsourced CIO, non-discretionary portfolio management, and investment consulting. Cambridge Associates maintains offices in Boston; Arlington, VA; Beijing; Dallas; London; Menlo Park, CA; New York; San Francisco; Singapore; Sydney; and Toronto. Cambridge Associates consists of five global investment consulting affiliates that are all under common ownership and control. For more information, please visit www.cambridgeassociates.com.